Use of Stem Cells in Drug Screening
Reference36 articles.
1. Aguilar Hernández R, Sánchez De Las Matas MJ, Arriagada C, Barcia C, Caviedes P, Herrero MT, Segura-Aguilar J (2003) MPP(+)-induced degeneration is potentiated by dicoumarol in cultures of the RCSN-3 dopaminergic cell line. Implications of neuromelanin in oxidative metabolism of dopamine neurotoxicity. Neurotox Res 5(6):407–410
2. Andrews PW, Meyer LJ, Bednarz KL, Harris H (1984) Two monoclonal antibodies recognizing determinants on human embryonal carcinoma cells react specifically with the liver isozyme of human alkaline phosphatase. Hybridoma 3(1):33–39
3. Arriagada R, Le Péchoux C, Baeza MR (2003) Prophylactic cranial irradiation in high-risk non-small cell lung cancer patients. Lung Cancer 42(Suppl 2):S41–S45
4. Augusti-Tocco G, Sato G (1969) Establishment of functional clonal lines of neurons from mouse neuroblastoma. Proc Natl Acad Sci U S A 64(1):311–315
5. Allen DD et al (2005). Cell lines as in vitro models for drug screening and toxicity studies. Drug Dev Ind Pharm 31(8):757–768